Your browser doesn't support javascript.
loading
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors.
Anderson, Nathaniel D; de Borja, Richard; Young, Matthew D; Fuligni, Fabio; Rosic, Andrej; Roberts, Nicola D; Hajjar, Simon; Layeghifard, Mehdi; Novokmet, Ana; Kowalski, Paul E; Anaka, Matthew; Davidson, Scott; Zarrei, Mehdi; Id Said, Badr; Schreiner, L Christine; Marchand, Remi; Sitter, Joseph; Gokgoz, Nalan; Brunga, Ledia; Graham, Garrett T; Fullam, Anthony; Pillay, Nischalan; Toretsky, Jeffrey A; Yoshida, Akihiko; Shibata, Tatsuhiro; Metzler, Markus; Somers, Gino R; Scherer, Stephen W; Flanagan, Adrienne M; Campbell, Peter J; Schiffman, Joshua D; Shago, Mary; Alexandrov, Ludmil B; Wunder, Jay S; Andrulis, Irene L; Malkin, David; Behjati, Sam; Shlien, Adam.
Afiliação
  • Anderson ND; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • de Borja R; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Young MD; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Fuligni F; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
  • Rosic A; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Roberts ND; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Hajjar S; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
  • Layeghifard M; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Novokmet A; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Kowalski PE; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Anaka M; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Davidson S; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Zarrei M; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Id Said B; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Schreiner LC; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Marchand R; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Sitter J; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Gokgoz N; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Brunga L; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Graham GT; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Fullam A; Department of Oncology and Pediatrics, Georgetown University, Washington, DC, USA.
  • Pillay N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
  • Toretsky JA; University College London Cancer Institute, Huntley Street, London, UK.
  • Yoshida A; Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex, UK.
  • Shibata T; Department of Oncology and Pediatrics, Georgetown University, Washington, DC, USA.
  • Metzler M; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Somers GR; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Scherer SW; Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Sciences, The University of Tokyo, Minato-ku, Tokyo, Japan.
  • Flanagan AM; Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
  • Campbell PJ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Schiffman JD; Department of Pathology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Shago M; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Alexandrov LB; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Wunder JS; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Andrulis IL; The McLaughlin Centre, University of Toronto, Toronto, Ontario, Canada.
  • Malkin D; Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex, UK.
  • Behjati S; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Shlien A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
Science ; 361(6405)2018 08 31.
Article em En | MEDLINE | ID: mdl-30166462
ABSTRACT
Sarcomas are cancers of the bone and soft tissue often defined by gene fusions. Ewing sarcoma involves fusions between EWSR1, a gene encoding an RNA binding protein, and E26 transformation-specific (ETS) transcription factors. We explored how and when EWSR1-ETS fusions arise by studying the whole genomes of Ewing sarcomas. In 52 of 124 (42%) of tumors, the fusion gene arises by a sudden burst of complex, loop-like rearrangements, a process called chromoplexy, rather than by simple reciprocal translocations. These loops always contained the disease-defining fusion at the center, but they disrupted multiple additional genes. The loops occurred preferentially in early replicating and transcriptionally active genomic regions. Similar loops forming canonical fusions were found in three other sarcoma types. Chromoplexy-generated fusions appear to be associated with an aggressive form of Ewing sarcoma. These loops arise early, giving rise to both primary and relapse Ewing sarcoma tumors, which can continue to evolve in parallel.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Sarcoma de Ewing / Neoplasias de Tecidos Moles / Neoplasias Ósseas / Rearranjo Gênico / Proteínas de Fusão Oncogênica Limite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Science Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Sarcoma de Ewing / Neoplasias de Tecidos Moles / Neoplasias Ósseas / Rearranjo Gênico / Proteínas de Fusão Oncogênica Limite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Science Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá